XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value of Financial Instruments
 9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
The following table presents the financial instruments and liabilities that are carried at fair value and summarizes their valuation by the respective pricing levels as of September 30, 2024 and December 31, 2023:
 As of September 30, 2024
(In thousands)Total
Quoted Market Prices in Active Markets
 (Level 1)
Significant Other Observable Inputs
 (Level 2)
Significant Unobservable Inputs
 (Level 3)
Assets carried at fair value
Money market funds$6,089 $6,089 $— $— 
Time deposits13,090 — 13,090 — 
U.S. Government bonds and notes180,035 — 180,035 — 
Corporate bonds, commercial paper and notes132,373 — 132,373 — 
Total assets carried at fair value$331,587 $6,089 $325,498 $— 
 As of December 31, 2023
(In thousands)Total
Quoted Market Prices in Active Markets
 (Level 1)
Significant Other Observable Inputs
 (Level 2)
Significant Unobservable Inputs
 (Level 3)
Assets carried at fair value
Money market funds$3,790 $3,790 $— $— 
U.S. Government bonds and notes196,919 — 196,919 — 
Corporate bonds, commercial paper and notes136,649 — 136,649 — 
Total available-for-sale securities$337,358 $3,790 $333,568 $— 
Liabilities carried at fair value
Earn-out liability related to the PLDA acquisition$12,500 $— $— $12,500 
Total liabilities carried at fair value$12,500 $— $— $12,500 
The Company’s liabilities related to earn-out liability were classified within Level 3 of the fair value hierarchy because the fair value was determined using significant unobservable inputs. The following table presents additional information about liabilities measured at fair value for which the Company utilizes Level 3 inputs to determine fair value, as of September 30, 2024 and 2023.
Three Months EndedNine Months Ended
September 30,September 30,
(In thousands)2024202320242023
Balance as of beginning of period$12,000 $28,600 $12,500 $14,800 
Change in fair value of earn-out liability due to remeasurement(4,544)(5,666)(5,044)8,134 
Change in fair value of earn-out liability due to achievement of revenue target(7,456)(11,534)(7,456)(11,534)
Balance as of end of period$— $11,400 $— $11,400 
For the three and nine months ended September 30, 2024 and 2023, the changes in the fair value of the earn-out liability related to the 2021 acquisition of PLDA, which was subject to certain revenue targets of the acquired business for a period of three years from the date of acquisition, and which is settled annually in shares of the Company’s common stock based on the fair value of that common stock fixed at the time the Company acquired PLDA. The fair value of the earn-out liability was remeasured each quarter, depending on the acquired business’s revenue performance relative to target over the applicable period, and adjusted to reflect changes in the per share value of the Company’s common stock. The Company classified its liability for the contingent earn-out liability related to the PLDA acquisition within Level 3 of the fair value hierarchy because the fair value calculation included significant unobservable inputs, such as revenue forecast, revenue volatility, equity volatility and weighted-average cost of capital. During the three and nine months ended September 30, 2024, the Company remeasured the fair value of the earn-out liability, which resulted in reductions of $4.5 million and $5.0 million, respectively, in the Company’s Unaudited Condensed Consolidated Statements of Operations. During the three and nine months ended September 30, 2023, the Company remeasured the fair value of the earn-out liability, which resulted in a reduction of $5.7 million and additional expenses of $8.1 million, respectively, in the Company’s Unaudited Condensed Consolidated Statements of Operations. The final earn-out was achieved as of September 30, 2024 and is expected to be fully paid during the fourth quarter of 2024.
The Company monitors its investments for impairment and records appropriate reductions in carrying value when necessary. The Company monitors its investments for impairment by considering current factors, including the economic environment, market conditions, operational performance and other specific factors relating to the business underlying the investment, reductions in carrying values when necessary and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in the market. Any impairment is reported under “Interest and other income (expense), net” in the Unaudited Condensed Consolidated Statements of Operations.
In 2018, the Company made an investment in a non-marketable equity security of a private company. This equity investment was accounted for under the equity method of accounting, and the Company accounted for its equity method share of the income (loss) on a quarterly basis. During the fourth quarter of 2023, the Company sold its 25.0% ownership share in the equity investment for approximately $25.0 million, which represented a gross gain on this transaction for the same amount. The gross gain was offset by transaction costs of approximately $1.1 million, resulting in a net gain of approximately $23.9 million, which was included in the Company’s Consolidated Statement of Operations for the year ended December 31, 2023. Subsequently, the Company received proceeds, net of tax, of approximately $22.8 million from this transaction during the first quarter of 2024.
During the three and nine months ended September 30, 2024 and 2023, there were no transfers of financial instruments between different categories of fair value.